美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

信息服務

4.95

+0.13002.70%

盤後：4.960.0100+0.20%18:42 EDT

成交量：27.19萬

成交額：133.98萬

市值：2.39億

市盈率：31.62

高：4.98

開：4.85

低：4.81

收：4.82

資料載入中...

總覽公司新聞資訊公告

深圳：以最大力度最快速度推動軟件和信息服務業快速增長

君實生物：特瑞普利單抗聯合貝伐珠單抗一線治療晚期肝細胞癌的新適應症上市申請獲得批准

華創證券：維持中國移動“推薦”評級，經營性現金流顯著改善

開拓藥業-B大漲超27% KX-826治療脱髮的長期安全性III期臨牀試驗達主要終點

港股異動 | 開拓藥業-B(09939)大漲超26% KX-826治療脱髮的長期安全性III期臨牀試驗達主要終點

荃信生物-B(02509)：QX005N結節性癢疹III期臨牀試驗順利完成受試者入組

開拓藥業-B(09939)：KX-826治療脫髮的長期安全性III期臨牀試驗達到主要終點

2024年上海落地億元以上項目近兩千個、總投資超1萬億元

北京世橋生物製藥有限公司申請III類會議

鄭州安圖實業集團股份有限公司申請III類會議

美股異動 | 和黃醫藥(HCM.US)漲8% 治療晚期腎細胞癌的FRUSICA-2中國II/III期研究達主要終點

和黃醫藥與信達生物宣佈呋喹替尼 (fruquintinib) 聯合信迪利單抗 (sintilimab) 用於治療晚期腎細胞癌的FRUSICA-2中國II/III期研究達到主要終點

港股異動 | 榮昌生物(09995)現漲超7% 泰它西普III期研究結果將於2025年AAN上重磅口頭彙報

和黃醫藥、信達生物：呋喹替尼聯合信迪利單抗用於治療晚期腎細胞癌的FRUSICA-2中國II/III期研究達到主要終點

和黃醫藥(00013)與信達生物宣佈呋喹替尼 (fruquintinib) 聯合信迪利單抗 (sintilimab) 用於治療晚期腎細胞癌的FRUSICA-2中國II/III期研究達到主要終點

天音控股在長春成立信息服務公司

阿斯利康10.5億美元收購的罕見病新藥首個關鍵III期研究成功

南昌谷森生物製藥有限公司申請III類會議

信達生物(01801)啓動瑪仕度肽VS司美格魯肽治療代謝相關脂肪性肝病III期臨牀

智通财经网

上海加快信息服務業與工業服務業創新發展，推動服務業提質升級

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/III/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"III","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","market":"US","secType":"STK","nameCN":"信息服務","latestPrice":4.95,"timestamp":1747252800000,"preClose":4.82,"halted":0,"volume":271902,"hourTrading":{"tag":"盘后","latestPrice":4.96,"preClose":4.95,"latestTime":"18:42 EDT","volume":4491,"amount":22232.44,"timestamp":1747262554820},"delay":0,"floatShares":34401437,"shares":48204172,"eps":0.156567,"marketStatus":"未開盤","change":0.13,"latestTime":"05-14 16:00:00 EDT","open":4.85,"high":4.98,"low":4.8101,"amount":1339849.310184,"amplitude":0.035249,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.156567,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1747296000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1171256400000,"exchange":"NASDAQ","adjPreClose":4.82,"dividendRate":0.036364,"postHourTrading":{"tag":"盘后","latestPrice":4.96,"preClose":4.95,"latestTime":"18:42 EDT","volume":4491,"amount":22232.44,"timestamp":1747262554820},"volumeRatio":0.857544,"impliedVol":1.9152,"impliedVolPercentile":0.984},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","floatShares":34401437,"roa":"3.30%","roe":"8.09%","lyrEps":0.058194,"volumeRatio":0.857544,"shares":48204172,"dividePrice":0.18,"high":4.98,"amplitude":0.035249,"preClose":4.82,"low":4.8101,"week52Low":2.92,"pbRate":"2.51","psRate":"0.98","week52High":4.98,"institutionHeld":0.6217,"latestPrice":4.95,"eps":0.156567,"divideRate":0.036364,"volume":271902,"delay":0,"ttmEps":0.156567,"open":4.85,"prevYearClose":3.34,"prevWeekClose":4.64,"prevMonthClose":3.88,"prevQuarterClose":3.91,"fiveDayClose":3.95,"twentyDayClose":3.53,"sixtyDayClose":3.16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"III\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521402481","title":"深圳：以最大力度最快速度推動軟件和信息服務業快速增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2521402481","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521402481?lang=zh_tw&edition=fundamental","pubTime":"2025-03-21 19:19","pubTimestamp":1742555943,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4134","161030","III","300959","BK0231"],"gpt_icon":0},{"id":"2521476765","title":"君實生物：特瑞普利單抗聯合貝伐珠單抗一線治療晚期肝細胞癌的新適應症上市申請獲得批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2521476765","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521476765?lang=zh_tw&edition=fundamental","pubTime":"2025-03-21 16:42","pubTimestamp":1742546525,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["01877","BK0239","688180","BK4134","BK1583","BK1515","III","BK1161"],"gpt_icon":0},{"id":"2521425497","title":"華創證券：維持中國移動“推薦”評級，經營性現金流顯著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2521425497","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521425497?lang=zh_tw&edition=fundamental","pubTime":"2025-03-21 14:16","pubTimestamp":1742537763,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1497734951.SGD","LU0164865239.USD","BK1521","SGXZ81163826.USD","159399","SGXZ49509284.SGD","LU0516422366.SGD","LU1226287529.USD","LU1497733557.USD","BK0261","LU1634259557.SGD","LU1328615791.USD","LU0531971595.HKD","BK4134","LU2148510915.USD","161027","LU1226288253.USD","600941","CHL","LU0039217434.USD","LU0516423174.USD","LU1226287875.USD","LU0871576103.HKD","SG9999002463.SGD","LU0149721374.USD","LU1481107354.HKD","80883","BK1589","LU0164880469.USD","BK1152","LU0516422952.EUR","BK1610","III","LU1522347837.USD","LU1226288170.HKD","LU0516422440.USD","BK1536","BK1506","LU1064130708.USD","LU1226287792.SGD","LU1951186391.HKD","LU0516423091.SGD","LU1634259391.SGD","LU1064131003.USD","00941","LU1497733631.SGD"],"gpt_icon":0},{"id":"2521417509","title":"開拓藥業-B大漲超27% KX-826治療脱髮的長期安全性III期臨牀試驗達主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2521417509","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521417509?lang=zh_tw&edition=fundamental","pubTime":"2025-03-21 09:43","pubTimestamp":1742521380,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　开拓药业-B（09939）早盘大涨27.19%，现报1.45港元，成交额1139.94万港元。\n　　开拓药业宣布其自主研发、潜在同类首创的KX-826酊治疗脱发的长期安全性III期临床试验已获得顶线数据。数据显示，该项长期安全性临床试验达到主要研究终点，结果具有统计学显著性及临床意义，且安全性和有效性均表现出色。该项长期安全性临床试验是一项多中心、开放标签研究，旨在评估KX-826外用治疗中国脱发患者的长期安全性（治疗时间52周）。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-03-21/doc-ineqkqss3025746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","III","03347","BK4134","09939","BK1515","BK1161","BK1574","BK1141","BK1576"],"gpt_icon":0},{"id":"2521412254","title":"港股異動 | 開拓藥業-B(09939)大漲超26% KX-826治療脱髮的長期安全性III期臨牀試驗達主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2521412254","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521412254?lang=zh_tw&edition=fundamental","pubTime":"2025-03-21 09:32","pubTimestamp":1742520769,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，开拓药业-B大涨超26%，截至发稿，涨26.32%，报1.44港元，成交额627.72万港元。消息面上，开拓药业宣布其自主研发、潜在同类首创的KX-826酊治疗脱发的长期安全性III期临床试验已获得顶线数据。数据显示，该项长期安全性临床试验达到主要研究终点，结果具有统计学显著性及临床意义，且安全性和有效性均表现出色。该项长期安全性临床试验是一项多中心、开放标签研究，旨在评估KX-826外用治疗中国脱发患者的长期安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1265186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1583","BK4134","BK1515","BK1574","III","BK1141","BK1576","03347","09939"],"gpt_icon":0},{"id":"2520434833","title":"荃信生物-B(02509)：QX005N結節性癢疹III期臨牀試驗順利完成受試者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2520434833","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520434833?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 18:19","pubTimestamp":1742465943,"startTime":"0","endTime":"0","summary":"2024年1月31日，QX005N被国家药品监督管理局药品审评中心纳入突破性治疗品种名单，对应适应症即为PN。本试验是一项评价QX005N在治疗PN成人受试者中的有效性和安全性的多中心、随机、双盲、安慰剂对照的III期临床研究，其主要研究目的是评估QX005N在PN受试者中对瘙痒缓解的有效性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1264843.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","BK4134","BK1576","02509","BK1161","BK1583","III","BK1141"],"gpt_icon":0},{"id":"2520436390","title":"開拓藥業-B(09939)：KX-826治療脫髮的長期安全性III期臨牀試驗達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2520436390","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520436390?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 17:34","pubTimestamp":1742463242,"startTime":"0","endTime":"0","summary":"智通财经APP讯，开拓药业-B 发布公告，公司自主研发、潜在同类首创的KX-826酊治疗脱发的长期安全性III期临床试验已获得顶线数据。该项长期安全性临床试验是一项多中心、开放标签研究，旨在评估KX-826外用治疗中国脱发患者的长期安全性。临床试验结果显示：安全性方面：KX-826酊在临床试验显示出令人满意的安全性和耐受性，整体不良事件发生率低，未出现死亡病例。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1264785.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","BK1161","BK4134","BK1515","BK1576","BK1583","BK1574","III","03347","BK1141"],"gpt_icon":1},{"id":"2520103169","title":"2024年上海落地億元以上項目近兩千個、總投資超1萬億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2520103169","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520103169?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 14:38","pubTimestamp":1742452720,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159638","III","000097.SH","BK4134"],"gpt_icon":0},{"id":"2520609194","title":"北京世橋生物製藥有限公司申請III類會議","url":"https://stock-news.laohu8.com/highlight/detail?id=2520609194","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520609194?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 05:11","pubTimestamp":1742418666,"startTime":"0","endTime":"0","summary":"北京世桥生物制药有限公司，成立于2002年，位于北京市，是一家以从事医药制造业为主的企业。通过天眼查大数据分析，北京世桥生物制药有限公司共对外投资了1家企业，参与招投标项目381次，知识产权方面有商标信息57条，专利信息19条，此外企业还拥有行政许可61个。主要股东信息显示，北京世桥生物制药有限公司由林韶辉持股31.8266%、冯桂深持股31.8266%、云穗生持股31.8266%、海南康永药品有限公司持股4.5203%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/20051148882567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["III","BK4134"],"gpt_icon":0},{"id":"2520519468","title":"鄭州安圖實業集團股份有限公司申請III類會議","url":"https://stock-news.laohu8.com/highlight/detail?id=2520519468","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520519468?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 05:11","pubTimestamp":1742418666,"startTime":"0","endTime":"0","summary":"郑州安图实业集团股份有限公司，成立于2007年，位于郑州市，是一家以从事批发业为主的企业。通过天眼查大数据分析，郑州安图实业集团股份有限公司共对外投资了14家企业，参与招投标项目2次，知识产权方面有商标信息18条，专利信息13条，此外企业还拥有行政许可8个。主要股东信息显示，郑州安图实业集团股份有限公司由苗拥军持股38.047%、杨增利持股9.1633%、吴学炜持股9.1633%、房瑞宽持股5.3447%、谢媛媛持股5.3447%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/20051148882570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4134","III"],"gpt_icon":0},{"id":"2520982153","title":"美股異動 | 和黃醫藥(HCM.US)漲8% 治療晚期腎細胞癌的FRUSICA-2中國II/III期研究達主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2520982153","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520982153?lang=zh_tw&edition=fundamental","pubTime":"2025-03-19 23:12","pubTimestamp":1742397162,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周三，和黄医药(HCM.US)涨8%，报16.16美元。消息面上，和黄医药和信达生物制药集团(Innovent Biologics, Inc. ，简称“信达生物”或 “Innovent”)今日联合宣布呋喹替尼 (fruquintinib)和信迪利单抗 (sintilimab)联合疗法用于二线治疗局部晚期或转移性肾细胞癌的FRUSICA-2中国II/III期研究已达到盲态独立中心阅片(BICR)根据 RECIST 1.1标准评估的无进展生存期(“PFS”)的主要终点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1264398.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","BK1588","00013","BK1191","BK4134","HCM","BK4531","BK4585","III","BK1587","BK4588"],"gpt_icon":0},{"id":"2520798904","title":"和黃醫藥與信達生物宣佈呋喹替尼 (fruquintinib) 聯合信迪利單抗 (sintilimab) 用於治療晚期腎細胞癌的FRUSICA-2中國II/III期研究達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2520798904","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520798904?lang=zh_tw&edition=fundamental","pubTime":"2025-03-19 10:17","pubTimestamp":1742350620,"startTime":"0","endTime":"0","summary":"香港、上海和新泽西州2025年3月19日 /美通社/ -- 和黄医药（中国）有限公司和信达生物制药集团今日联合宣布呋喹替尼和信迪利单抗联合疗法用于二线治疗局部晚期或转移性肾细胞癌的FRUSICA-2中国II/III期研究已达到盲态独立中心阅片根据RECIST 1.1标准评估的无进展生存期的主要终点。这些结果不仅突显了呋喹替尼和信迪利单抗联合疗法巨大的潜力，也为经治的晚期肾细胞癌患者带来新的希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4644599_ZH44599_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1587","BK1191","III","BK4531","BK4588","BK4007","BK1588","BK4585","HCM","00013","BK4134"],"gpt_icon":0},{"id":"2520496718","title":"港股異動 | 榮昌生物(09995)現漲超7% 泰它西普III期研究結果將於2025年AAN上重磅口頭彙報","url":"https://stock-news.laohu8.com/highlight/detail?id=2520496718","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520496718?lang=zh_tw&edition=fundamental","pubTime":"2025-03-19 09:46","pubTimestamp":1742348806,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荣昌生物现涨超7%，截至发稿，涨7.29%，报20.15港元，成交额4650.56万港元。消息面上，荣昌生物今日宣布，公司自主研发的BLyS/APRIL双靶点融合蛋白创新药泰它西普用于治疗全身型重症肌无力Ⅲ期研究结果，作为“最新突破性研究”入选2025年美国神经病学会年会重磅口头报告。此外，荣昌生物拟于3月27日举行董事会会议批准年度业绩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1263834.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","LU1969619763.USD","BK1583","688331","LU2148510915.USD","LU2328871848.SGD","LU1064131003.USD","LU1064130708.USD","BK4178","AAN","BK1574","III","BK4134","09995","BK1161"],"gpt_icon":0},{"id":"2520650969","title":"和黃醫藥、信達生物：呋喹替尼聯合信迪利單抗用於治療晚期腎細胞癌的FRUSICA-2中國II/III期研究達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2520650969","media":"界面","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520650969?lang=zh_tw&edition=fundamental","pubTime":"2025-03-19 08:43","pubTimestamp":1742345018,"startTime":"0","endTime":"0","summary":"3月19日，和黄医药（中国）有限公司和信达生物制药集团宣布，呋喹替尼和信迪利单抗联合疗法用于二线治疗局部晚期或转移性肾细胞癌的FRUSICA-2中国II/III期研究已达到盲态独立中心阅片（BICR）根据RECIST 1.1标准评估的无进展生存期的主要终点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250319084338a69b38fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250319084338a69b38fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","III","BK4531","HCM","BK4134","BK4585","BK4007"],"gpt_icon":0},{"id":"2520879968","title":"和黃醫藥(00013)與信達生物宣佈呋喹替尼 (fruquintinib) 聯合信迪利單抗 (sintilimab) 用於治療晚期腎細胞癌的FRUSICA-2中國II/III期研究達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2520879968","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520879968?lang=zh_tw&edition=fundamental","pubTime":"2025-03-19 08:10","pubTimestamp":1742343054,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和黄医药 发布公告，和黄医药(中国)有限公司和信达生物制药集团今日联合宣布呋喹替尼 和信迪利单抗 联合疗法用于二线治疗局部晚期或转移性肾细胞癌的FRUSICA-2中国II/III期研究已达到盲态独立中心阅片根据 RECIST 1.1标准评估的无进展生存期的主要终点。FRUSICA-2研究是一项随机、开放标签、阳性对照的临床试验，旨在评估呋喹替尼和信迪利单抗联合疗法对比阿昔替尼或依维莫司单药疗法用于二线治疗晚期肾细胞癌的疗效和安全性  。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1263795.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00013","BK1587","BK4007","01801","BK4134","BK1589","BK4531","BK4585","HCM","BK1191","BK1161","III","LU2488822045.USD","BK1583","BK4588","LU2328871848.SGD","LU1969619763.USD","BK1588"],"gpt_icon":1},{"id":"2520698464","title":"天音控股在長春成立信息服務公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2520698464","media":"企查查","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520698464?lang=zh_tw&edition=fundamental","pubTime":"2025-03-18 13:42","pubTimestamp":1742276539,"startTime":"0","endTime":"0","summary":"企查查APP显示，近日，天音信息服务（长春）有限公司成立，法定代表人为王凤宁，注册资本100万元，经营范围包含：物联网技术服务；5G通信技术服务；音响设备销售等。企查查股权穿透显示，该公司由天音控股（000829）间接全资持股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318134327971a9fe7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318134327971a9fe7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["III","BK4134"],"gpt_icon":0},{"id":"2520639760","title":"阿斯利康10.5億美元收購的罕見病新藥首個關鍵III期研究成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2520639760","media":"医药魔方","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520639760?lang=zh_tw&edition=fundamental","pubTime":"2025-03-18 08:00","pubTimestamp":1742256027,"startTime":"0","endTime":"0","summary":"3月17日，阿斯利康宣布III期CALYPSO研究取得积极结果，该研究旨在评估 eneboparatide在成人慢性甲状旁腺功能减退症患者中的疗效和安全性。Eeneboparatide是2024年3月阿斯利康以10.5亿美元收购Amolyt Pharm获得的一款甲状旁腺激素受体1激动剂。CALYPSO研究成为该药首个达到主要终点的III期临床研究，验证了其临床获益。在24周的主要治疗期后，所有患者延长接受eneboparatide治疗，直至52周。HypoPT是已知最大的罕见疾病之一，在美国和欧盟影响超过20万人，其中约80%是女性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318081509a43752e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318081509a43752e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0109394709.USD","LU0320765992.SGD","LU2236285917.USD","BK4568","LU2417539215.USD","LU2456880835.USD","LU1829250122.USD","BK4007","LU2462157665.USD","AZN","III","BK4585","BK4134","LU0889565916.HKD"],"gpt_icon":0},{"id":"2520383846","title":"南昌谷森生物製藥有限公司申請III類會議","url":"https://stock-news.laohu8.com/highlight/detail?id=2520383846","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520383846?lang=zh_tw&edition=fundamental","pubTime":"2025-03-18 07:06","pubTimestamp":1742252763,"startTime":"0","endTime":"0","summary":"金融界3月18日消息，据CDE官网沟通交流公示，于3月18日收到南昌谷森生物制药有限公司申请的“III类会议”，当前状态“处理中”。南昌谷森生物制药有限公司，成立于2018年，位于南昌市，是一家以从事医药制造业为主的企业。通过天眼查大数据分析，南昌谷森生物制药有限公司参与招投标项目2次，专利信息3条，此外企业还拥有行政许可4个。主要股东信息显示，南昌谷森生物制药有限公司由上海谷森医药有限公司持股100%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/18070648811787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["III","BK4134"],"gpt_icon":0},{"id":"2520248225","title":"信達生物(01801)啓動瑪仕度肽VS司美格魯肽治療代謝相關脂肪性肝病III期臨牀","url":"https://stock-news.laohu8.com/highlight/detail?id=2520248225","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520248225?lang=zh_tw&edition=fundamental","pubTime":"2025-03-17 21:24","pubTimestamp":1742217842,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月14日，药物临床试验登记与信息公示平台显示，信达启动了一项在中国超重或肥胖合并代谢相关脂肪性肝病受试者中比较玛仕度肽与司美格鲁肽有效性和安全性的多中心、随机、开放标签的III期临床研究。目前，玛仕度肽在中国超重或肥胖受试者和2型糖尿病受试者中的多项III期临床研究正在进行中。其中， GLORY-1和DREAMS-2研究已经达成主要终点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1263067.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU2328871848.SGD","BK1161","01801","LU1969619763.USD","III","LU2488822045.USD","BK1589","BK4134","VS","BK1583","BK4085"],"gpt_icon":0},{"id":"2520528378","title":"上海加快信息服務業與工業服務業創新發展，推動服務業提質升級","url":"https://stock-news.laohu8.com/highlight/detail?id=2520528378","media":"媒体滚动","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520528378?lang=zh_tw&edition=fundamental","pubTime":"2025-03-17 19:33","pubTimestamp":1742211180,"startTime":"0","endTime":"0","summary":"市经济信息化委表示，《措施》创新突破多、政策力度大，对本市信息服务业、工业服务业等重点产业的进一步发展具有重要推进作用，市经信委将贯彻落实政策任务分工，重点做好以下工作，助力本市服务业创新发展。一是强化企业引育，通过上海全球投资促进大会、“投资上海”系列活动等重点活动，加强招商引资力度，围绕上海市产业地图和各区主导产业，引进优质信息服务业、工业服务业企业，完善产业链条，加快培育服务业新质生产力。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-03-17/doc-inepymna0380082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4134","III"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/III\",params:#limit:5,,,undefined,":[{"date":"2025-07-10","symbol":"III","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1752134400000,"name":null,"time":"盤前","dateTimestamp":1752120000000,"actualEps":null},{"date":"2025-06-06","symbol":"III","amount":0.045,"announcedDate":"2025-05-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-06","defaultRemindTime":1749216600000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-06","currency":"USD","dateTimestamp":1749182400000,"payDate":"2025-06-27"},{"market":"US","date":"2025-05-08","symbol":"III","fiscalQuarterEnding":"2025/03","expectedEps":0.04,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":0.04},{"date":"2025-03-21","symbol":"III","amount":0.045,"announcedDate":"2025-03-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"market":"US","date":"2025-03-06","symbol":"III","fiscalQuarterEnding":"2024/12","expectedEps":0.02,"name":null,"time":"盤後","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":0.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"III\",market:\"US\",,,undefined,":[{"executeDate":"2021-06-03","recordDate":"2021-06-04","paymentDate":"2021-06-18","value":0.03,"currency":"USD"},{"executeDate":"2021-09-03","recordDate":"2021-09-07","paymentDate":"2021-09-24","value":0.03,"currency":"USD"},{"executeDate":"2021-12-02","recordDate":"2021-12-03","paymentDate":"2021-12-17","value":0.03,"currency":"USD"},{"executeDate":"2022-03-18","recordDate":"2022-03-21","paymentDate":"2022-04-06","value":0.03,"currency":"USD"},{"executeDate":"2022-06-02","recordDate":"2022-06-03","paymentDate":"2022-06-17","value":0.04,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"III\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1679457600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/III\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"III","date":"2025-05-13","current":29.987043,"percent":0.636881,"low":-221.876594,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"high":85.733259,"avg":5.512565,"sd":61.614971,"marketCap":231380025},"quantilePoints":[{"date":"2020-05-15","current":33.57217,"twenty":20.050829,"median":32.238884,"eighty":49.624683,"marketCap":96654276},{"date":"2020-05-22","current":28.776145,"twenty":20.050829,"median":32.183452,"eighty":49.624683,"marketCap":82846522},{"date":"2020-05-29","current":28.445385,"twenty":20.050829,"median":32.145891,"eighty":49.624683,"marketCap":81894263},{"date":"2020-06-05","current":35.060591,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":100939441},{"date":"2020-06-12","current":33.406789,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":96178146},{"date":"2020-06-19","current":33.241409,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":95702017},{"date":"2020-06-26","current":33.90293,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":97606535},{"date":"2020-07-02","current":35.556731,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":102367829},{"date":"2020-07-10","current":34.23369,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":98558794},{"date":"2020-07-17","current":34.23369,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":98558794},{"date":"2020-07-24","current":33.57217,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":96654276},{"date":"2020-07-31","current":33.90293,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":97606535},{"date":"2020-08-07","current":35.060591,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":100939441},{"date":"2020-08-14","current":36.396194,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":112027485},{"date":"2020-08-21","current":34.990332,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":107700243},{"date":"2020-08-28","current":32.491023,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":100007369},{"date":"2020-09-04","current":33.272057,"twenty":20.050829,"median":32.145891,"eighty":49.624683,"marketCap":102411392},{"date":"2020-09-11","current":32.100506,"twenty":20.050829,"median":32.155221,"eighty":49.624683,"marketCap":98805357},{"date":"2020-09-18","current":33.896885,"twenty":20.050829,"median":32.150556,"eighty":49.624683,"marketCap":104334611},{"date":"2020-09-25","current":32.178609,"twenty":20.050829,"median":32.143037,"eighty":49.624683,"marketCap":99045759},{"date":"2020-10-02","current":32.64723,"twenty":20.050829,"median":32.150556,"eighty":49.624683,"marketCap":100488173},{"date":"2020-10-09","current":33.584471,"twenty":20.050829,"median":32.166915,"eighty":49.624683,"marketCap":103373001},{"date":"2020-10-16","current":32.803437,"twenty":20.050829,"median":32.195146,"eighty":49.624683,"marketCap":100968978},{"date":"2020-10-23","current":32.803437,"twenty":20.050829,"median":32.271873,"eighty":49.624683,"marketCap":100968978},{"date":"2020-10-30","current":32.022403,"twenty":20.050829,"median":32.29645,"eighty":49.624683,"marketCap":98564955},{"date":"2020-11-06","current":37.645849,"twenty":20.050829,"median":32.334816,"eighty":49.624683,"marketCap":115873923},{"date":"2020-11-13","current":37.83975,"twenty":20.050829,"median":32.470567,"eighty":49.624683,"marketCap":128692991},{"date":"2020-11-20","current":37.698557,"twenty":20.050829,"median":32.551135,"eighty":49.624683,"marketCap":128212793},{"date":"2020-11-27","current":45.040598,"twenty":20.050829,"median":32.61356,"eighty":49.624683,"marketCap":153183075},{"date":"2020-12-04","current":44.052247,"twenty":20.055618,"median":32.732778,"eighty":49.624683,"marketCap":149821691},{"date":"2020-12-11","current":44.617019,"twenty":20.096237,"median":32.786479,"eighty":49.624683,"marketCap":151742482},{"date":"2020-12-18","current":46.170143,"twenty":20.444658,"median":32.803437,"eighty":49.624683,"marketCap":157024657},{"date":"2020-12-24","current":42.781509,"twenty":20.563355,"median":32.855737,"eighty":49.624683,"marketCap":145499912},{"date":"2020-12-31","current":46.311336,"twenty":20.775561,"median":32.958394,"eighty":49.624683,"marketCap":157504855},{"date":"2021-01-08","current":49.417585,"twenty":21.565226,"median":33.007951,"eighty":49.624683,"marketCap":168069205},{"date":"2021-01-15","current":55.771274,"twenty":21.971704,"median":33.076029,"eighty":50.098483,"marketCap":189678103},{"date":"2021-01-22","current":50.829515,"twenty":22.396936,"median":33.127057,"eighty":50.207132,"marketCap":172871182},{"date":"2021-01-29","current":49.841164,"twenty":22.679784,"median":33.261363,"eighty":50.440112,"marketCap":169509798},{"date":"2021-02-05","current":52.523833,"twenty":22.936122,"median":33.272057,"eighty":50.716561,"marketCap":178633555},{"date":"2021-02-12","current":52.523833,"twenty":23.262797,"median":33.398429,"eighty":51.059228,"marketCap":178633555},{"date":"2021-02-19","current":53.794571,"twenty":23.609141,"median":33.417527,"eighty":51.276882,"marketCap":182955335},{"date":"2021-02-26","current":51.394288,"twenty":23.816947,"median":33.569725,"eighty":51.732235,"marketCap":174791973},{"date":"2021-03-05","current":53.088605,"twenty":24.140202,"median":33.57217,"eighty":51.962271,"marketCap":180554346},{"date":"2021-03-12","current":77.651845,"twenty":24.664612,"median":33.630766,"eighty":52.202094,"marketCap":213930833},{"date":"2021-03-19","current":71.502943,"twenty":26.272494,"median":33.737549,"eighty":52.523833,"marketCap":196990608},{"date":"2021-03-26","current":76.77343,"twenty":26.854371,"median":33.859576,"eighty":52.626372,"marketCap":211510801},{"date":"2021-04-01","current":78.003211,"twenty":26.956092,"median":33.90293,"eighty":52.747595,"marketCap":214898846},{"date":"2021-04-09","current":75.895016,"twenty":27.210395,"median":33.991802,"eighty":52.906055,"marketCap":209090769},{"date":"2021-04-16","current":76.422065,"twenty":27.379781,"median":34.193624,"eighty":53.109266,"marketCap":210542788},{"date":"2021-04-23","current":77.124796,"twenty":27.464698,"median":34.23369,"eighty":53.271145,"marketCap":212478813},{"date":"2021-04-30","current":79.935723,"twenty":27.596809,"median":34.39907,"eighty":53.663807,"marketCap":220222916},{"date":"2021-05-07","current":85.733259,"twenty":27.758845,"median":34.72983,"eighty":53.929654,"marketCap":236195128},{"date":"2021-05-14","current":34.582604,"twenty":27.90985,"median":34.72983,"eighty":53.929654,"marketCap":260718251},{"date":"2021-05-21","current":37.193814,"twenty":27.984267,"median":34.89521,"eighty":53.929654,"marketCap":280404160},{"date":"2021-05-28","current":37.32119,"twenty":28.127158,"median":35.060591,"eighty":53.929654,"marketCap":281364448},{"date":"2021-06-04","current":35.665301,"twenty":28.201568,"median":35.178625,"eighty":53.929654,"marketCap":268880701},{"date":"2021-06-11","current":36.811685,"twenty":28.275979,"median":35.34686,"eighty":53.929654,"marketCap":277523295},{"date":"2021-06-18","current":35.283172,"twenty":28.317177,"median":35.460054,"eighty":53.929654,"marketCap":265999836},{"date":"2021-06-25","current":35.983741,"twenty":28.42477,"median":35.600769,"eighty":53.929654,"marketCap":271281422},{"date":"2021-07-02","current":38.27651,"twenty":28.559204,"median":35.741483,"eighty":53.929654,"marketCap":288566610},{"date":"2021-07-09","current":38.212822,"twenty":28.661781,"median":35.920053,"eighty":53.929654,"marketCap":288086466},{"date":"2021-07-16","current":36.174805,"twenty":28.841499,"median":36.238493,"eighty":53.929654,"marketCap":272721854},{"date":"2021-07-23","current":38.085446,"twenty":29.02216,"median":36.365869,"eighty":53.929654,"marketCap":287126177},{"date":"2021-07-30","current":38.021758,"twenty":29.112158,"median":36.556933,"eighty":53.929654,"marketCap":286646033},{"date":"2021-08-06","current":37.830694,"twenty":29.227833,"median":36.811685,"eighty":53.929654,"marketCap":285205601},{"date":"2021-08-13","current":30.04792,"twenty":29.342728,"median":36.811685,"eighty":53.929654,"marketCap":331488657},{"date":"2021-08-20","current":29.125396,"twenty":29.392136,"median":36.811685,"eighty":53.929654,"marketCap":321311374},{"date":"2021-08-27","current":31.014374,"twenty":29.446637,"median":36.811685,"eighty":53.929654,"marketCap":342150573},{"date":"2021-09-03","current":32.376195,"twenty":29.490206,"median":36.811685,"eighty":53.929654,"marketCap":357174181},{"date":"2021-09-10","current":33.869805,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":373651688},{"date":"2021-09-17","current":33.210859,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":366382200},{"date":"2021-09-24","current":32.859422,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":362505139},{"date":"2021-10-01","current":31.936898,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":352327856},{"date":"2021-10-08","current":33.386578,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-15","current":31.849038,"twenty":29.673426,"median":36.811685,"eighty":53.929654,"marketCap":351358591},{"date":"2021-10-22","current":33.386578,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-29","current":35.802712,"twenty":29.76934,"median":36.811685,"eighty":53.929654,"marketCap":394975520},{"date":"2021-11-05","current":32.443868,"twenty":29.838435,"median":36.811685,"eighty":53.929654,"marketCap":434715388},{"date":"2021-11-12","current":34.955794,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":468372678},{"date":"2021-11-19","current":34.77297,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":465923030},{"date":"2021-11-26","current":30.348649,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":406641551},{"date":"2021-12-03","current":28.886064,"twenty":29.82833,"median":36.811685,"eighty":53.929654,"marketCap":387044368},{"date":"2021-12-10","current":29.507663,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":395373171},{"date":"2021-12-17","current":26.984703,"twenty":29.661234,"median":36.811685,"eighty":53.929654,"marketCap":361568030},{"date":"2021-12-23","current":28.081642,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":376265917},{"date":"2021-12-31","current":27.862254,"twenty":29.504246,"median":36.811685,"eighty":53.929654,"marketCap":373326339},{"date":"2022-01-07","current":26.399668,"twenty":29.437039,"median":36.760945,"eighty":53.927618,"marketCap":353729156},{"date":"2022-01-14","current":25.302729,"twenty":29.255815,"median":36.760945,"eighty":53.927618,"marketCap":339031269},{"date":"2022-01-21","current":23.145416,"twenty":29.125104,"median":36.760945,"eighty":53.927618,"marketCap":310125424},{"date":"2022-01-28","current":22.670075,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":303756339},{"date":"2022-02-04","current":24.863954,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":333152114},{"date":"2022-02-11","current":25.887763,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":346870142},{"date":"2022-02-18","current":27.130961,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":363527748},{"date":"2022-02-25","current":26.107151,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":349809720},{"date":"2022-03-04","current":27.423478,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":367447185},{"date":"2022-03-11","current":22.999463,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":357158663},{"date":"2022-03-18","current":22.63323,"twenty":28.930434,"median":36.760945,"eighty":53.927618,"marketCap":351471428},{"date":"2022-03-25","current":21.138876,"twenty":28.720555,"median":36.760945,"eighty":53.927618,"marketCap":328265612},{"date":"2022-04-01","current":21.387935,"twenty":28.563876,"median":36.760945,"eighty":53.927618,"marketCap":332133248},{"date":"2022-04-08","current":20.640759,"twenty":28.47654,"median":36.760945,"eighty":53.927618,"marketCap":320530340},{"date":"2022-04-14","current":20.79642,"twenty":28.362763,"median":36.760945,"eighty":53.927618,"marketCap":322947612},{"date":"2022-04-22","current":19.769052,"twenty":28.214177,"median":36.760945,"eighty":53.927618,"marketCap":306993613},{"date":"2022-04-29","current":19.519993,"twenty":28.004454,"median":36.760945,"eighty":53.927618,"marketCap":303125977},{"date":"2022-05-06","current":18.430361,"twenty":27.931066,"median":36.760945,"eighty":53.927618,"marketCap":286205069},{"date":"2022-05-13","current":17.907825,"twenty":27.846885,"median":36.556933,"eighty":53.927618,"marketCap":305059795},{"date":"2022-05-20","current":17.625134,"twenty":27.555111,"median":36.381032,"eighty":53.927618,"marketCap":300244158},{"date":"2022-05-27","current":18.472496,"twenty":27.379781,"median":36.238493,"eighty":53.927618,"marketCap":314678973},{"date":"2022-06-03","current":18.274778,"twenty":27.167526,"median":36.092994,"eighty":53.927618,"marketCap":311310849},{"date":"2022-06-10","current":16.269354,"twenty":26.614253,"median":35.829538,"eighty":53.927618,"marketCap":277148453},{"date":"2022-06-17","current":16.551809,"twenty":26.372596,"median":35.640231,"eighty":53.822908,"marketCap":281960058},{"date":"2022-06-24","current":17.879343,"twenty":26.107151,"median":35.537925,"eighty":53.79462,"marketCap":304574602},{"date":"2022-07-01","current":19.093895,"twenty":25.975518,"median":35.458953,"eighty":53.271145,"marketCap":325264504},{"date":"2022-07-08","current":19.856521,"twenty":25.412423,"median":35.283172,"eighty":53.041064,"marketCap":338255838},{"date":"2022-07-15","current":19.291613,"twenty":24.849328,"median":35.178625,"eighty":52.906055,"marketCap":328632628},{"date":"2022-07-22","current":20.138975,"twenty":24.08147,"median":35.060591,"eighty":52.665026,"marketCap":343067443},{"date":"2022-07-29","current":21.071074,"twenty":23.209281,"median":34.955794,"eighty":52.523833,"marketCap":358945740},{"date":"2022-08-05","current":21.635982,"twenty":22.947966,"median":34.77297,"eighty":52.322009,"marketCap":368568950},{"date":"2022-08-12","current":16.409925,"twenty":22.628286,"median":34.72983,"eighty":52.322009,"marketCap":293507911},{"date":"2022-08-19","current":16.552576,"twenty":22.371718,"median":34.475053,"eighty":52.322009,"marketCap":296059374},{"date":"2022-08-26","current":16.15211,"twenty":21.544722,"median":34.282985,"eighty":52.322009,"marketCap":288896647},{"date":"2022-09-02","current":14.950714,"twenty":21.183009,"median":34.23369,"eighty":52.322009,"marketCap":267408467},{"date":"2022-09-09","current":14.817225,"twenty":21.074397,"median":34.193624,"eighty":52.322009,"marketCap":265020891},{"date":"2022-09-16","current":14.123085,"twenty":20.842582,"median":34.06831,"eighty":52.322009,"marketCap":252605498},{"date":"2022-09-23","current":12.948386,"twenty":20.628306,"median":33.98562,"eighty":52.322009,"marketCap":231594833},{"date":"2022-09-30","current":12.708107,"twenty":20.189817,"median":33.90293,"eighty":52.322009,"marketCap":227297197},{"date":"2022-10-07","current":12.761502,"twenty":19.975152,"median":33.869805,"eighty":52.322009,"marketCap":228252227},{"date":"2022-10-14","current":12.814898,"twenty":19.650749,"median":33.737549,"eighty":52.322009,"marketCap":229207257},{"date":"2022-10-21","current":13.268758,"twenty":19.370558,"median":33.630766,"eighty":52.322009,"marketCap":237325014},{"date":"2022-10-28","current":14.790528,"twenty":19.172983,"median":33.57217,"eighty":52.322009,"marketCap":264543376},{"date":"2022-11-04","current":11.924698,"twenty":18.940931,"median":33.57217,"eighty":52.322009,"marketCap":226819682},{"date":"2022-11-11","current":14.156908,"twenty":18.67839,"median":33.490051,"eighty":52.100253,"marketCap":269278547},{"date":"2022-11-18","current":14.055967,"twenty":18.383013,"median":33.406789,"eighty":51.591958,"marketCap":267358557},{"date":"2022-11-25","current":13.52603,"twenty":17.941577,"median":33.349337,"eighty":51.184669,"marketCap":257278611},{"date":"2022-12-02","current":13.223208,"twenty":17.811433,"median":33.272057,"eighty":50.857754,"marketCap":251518642},{"date":"2022-12-09","current":12.59233,"twenty":17.329516,"median":33.261363,"eighty":50.482919,"marketCap":239518707},{"date":"2022-12-16","current":11.406279,"twenty":16.879455,"median":33.138265,"eighty":50.207132,"marketCap":216958829},{"date":"2022-12-23","current":11.507219,"twenty":16.612253,"median":33.07907,"eighty":49.781169,"marketCap":218878818},{"date":"2022-12-30","current":11.60816,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":220798808},{"date":"2023-01-06","current":12.264273,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":233278741},{"date":"2023-01-13","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-01-20","current":12.970857,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246718668},{"date":"2023-01-27","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-02-03","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-10","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-17","current":13.677441,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":260158596},{"date":"2023-02-24","current":12.945622,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246238671},{"date":"2023-03-03","current":13.500795,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":256798614},{"date":"2023-03-10","current":12.166618,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239998705},{"date":"2023-03-17","current":11.411218,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":225097683},{"date":"2023-03-24","current":12.147425,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239620114},{"date":"2023-03-31","current":12.490989,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":246397249},{"date":"2023-04-06","current":12.294667,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":242524601},{"date":"2023-04-14","current":12.687311,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":250269897},{"date":"2023-04-21","current":12.270127,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":242040520},{"date":"2023-04-28","current":12.196506,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":240588276},{"date":"2023-05-05","current":12.245586,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":241556438},{"date":"2023-05-12","current":13.473902,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":246397249},{"date":"2023-05-19","current":14.20765,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":259815303},{"date":"2023-05-26","current":13.413927,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":245300481},{"date":"2023-06-02","current":13.387469,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":244816654},{"date":"2023-06-09","current":13.943076,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":254977029},{"date":"2023-06-16","current":14.075363,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":257396166},{"date":"2023-06-23","current":15.080746,"twenty":16.529212,"median":33.076029,"eighty":49.624683,"marketCap":275781606},{"date":"2023-06-30","current":14.154735,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":258847648},{"date":"2023-07-07","current":13.810789,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":252557892},{"date":"2023-07-14","current":14.260565,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":260782957},{"date":"2023-07-21","current":14.048906,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":256912338},{"date":"2023-07-28","current":13.387469,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":244816654},{"date":"2023-08-04","current":16.278939,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":254977029},{"date":"2023-08-11","current":16.275803,"twenty":16.382336,"median":32.997393,"eighty":49.558778,"marketCap":254927904},{"date":"2023-08-18","current":15.376759,"twenty":16.278939,"median":32.930248,"eighty":49.391703,"marketCap":240846172},{"date":"2023-08-25","current":15.40776,"twenty":16.232204,"median":32.835614,"eighty":49.042233,"marketCap":241331749},{"date":"2023-09-01","current":16.120795,"twenty":16.15211,"median":32.803437,"eighty":48.925743,"marketCap":252500019},{"date":"2023-09-08","current":15.035742,"twenty":16.031821,"median":32.75433,"eighty":48.809254,"marketCap":235504825},{"date":"2023-09-15","current":14.446713,"twenty":15.779779,"median":32.64723,"eighty":48.576274,"marketCap":226278863},{"date":"2023-09-22","current":13.733678,"twenty":15.562768,"median":32.609831,"eighty":48.459784,"marketCap":215110593},{"date":"2023-09-29","current":13.423662,"twenty":15.404575,"median":32.491023,"eighty":48.459784,"marketCap":210254823},{"date":"2023-10-06","current":13.950688,"twenty":15.345757,"median":32.431996,"eighty":48.459784,"marketCap":218509632},{"date":"2023-10-13","current":13.361659,"twenty":15.080746,"median":32.334816,"eighty":48.343294,"marketCap":209283669},{"date":"2023-10-20","current":13.051644,"twenty":14.911736,"median":32.178609,"eighty":48.324535,"marketCap":204427900},{"date":"2023-10-27","current":12.77263,"twenty":14.827387,"median":32.156546,"eighty":48.226804,"marketCap":200057707},{"date":"2023-11-03","current":15.032891,"twenty":14.614323,"median":32.100506,"eighty":48.180208,"marketCap":200057707},{"date":"2023-11-10","current":15.314305,"twenty":14.614323,"median":32.044484,"eighty":48.063719,"marketCap":203802770},{"date":"2023-11-17","current":15.975354,"twenty":14.614323,"median":32.022403,"eighty":47.932458,"marketCap":212600012},{"date":"2023-11-24","current":16.048804,"twenty":14.614323,"median":31.943078,"eighty":47.714249,"marketCap":213577483},{"date":"2023-12-01","current":15.27758,"twenty":14.614323,"median":31.841671,"eighty":47.187487,"marketCap":203314034},{"date":"2023-12-08","current":16.673128,"twenty":14.619662,"median":31.750721,"eighty":46.490677,"marketCap":221885989},{"date":"2023-12-15","current":16.673128,"twenty":14.619662,"median":31.53949,"eighty":46.22662,"marketCap":221885989},{"date":"2023-12-22","current":17.407627,"twenty":14.619662,"median":31.467912,"eighty":45.230776,"marketCap":231660702},{"date":"2023-12-29","current":17.554527,"twenty":14.614323,"median":31.234022,"eighty":45.040598,"marketCap":233615645},{"date":"2024-01-05","current":16.673128,"twenty":14.608983,"median":31.080268,"eighty":44.740412,"marketCap":221885989},{"date":"2024-01-12","current":16.452778,"twenty":14.608983,"median":30.97496,"eighty":44.593596,"marketCap":218953575},{"date":"2024-01-19","current":16.269154,"twenty":14.603644,"median":30.818124,"eighty":44.593596,"marketCap":216509897},{"date":"2024-01-26","current":17.554527,"twenty":14.608983,"median":30.62605,"eighty":44.463847,"marketCap":233615645},{"date":"2024-02-02","current":16.820028,"twenty":14.608983,"median":30.523385,"eighty":44.220503,"marketCap":223840932},{"date":"2024-02-09","current":16.122254,"twenty":14.608983,"median":30.418362,"eighty":43.923358,"marketCap":214554954},{"date":"2024-02-16","current":16.305879,"twenty":14.608983,"median":30.260593,"eighty":43.769861,"marketCap":216998633},{"date":"2024-02-23","current":15.608105,"twenty":14.608983,"median":30.141793,"eighty":42.75327,"marketCap":207712655},{"date":"2024-03-01","current":15.901904,"twenty":14.614323,"median":30.092043,"eighty":42.030433,"marketCap":211622540},{"date":"2024-03-08","current":34.784891,"twenty":14.614323,"median":29.930691,"eighty":41.395649,"marketCap":214066219},{"date":"2024-03-15","current":30.710223,"twenty":14.614323,"median":29.930691,"eighty":41.308941,"marketCap":188990710},{"date":"2024-03-22","current":32.281078,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":198657754},{"date":"2024-03-28","current":31.652736,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":194790936},{"date":"2024-04-05","current":31.966907,"twenty":14.608983,"median":30.092453,"eighty":41.339259,"marketCap":196724345},{"date":"2024-04-12","current":30.238966,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":186090597},{"date":"2024-04-19","current":28.589568,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":175940200},{"date":"2024-04-26","current":27.411426,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":168689917},{"date":"2024-05-03","current":26.39037,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":162406339},{"date":"2024-05-10","current":25.919114,"twenty":14.614323,"median":30.117759,"eighty":41.308941,"marketCap":159506226},{"date":"2024-05-17","current":-211.151442,"twenty":14.503289,"median":29.916131,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-24","current":-211.151442,"twenty":14.319403,"median":29.768426,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-31","current":-216.514018,"twenty":14.260565,"median":29.603046,"eighty":41.308941,"marketCap":157189177},{"date":"2024-06-07","current":-209.810798,"twenty":14.204967,"median":29.476834,"eighty":41.308941,"marketCap":152322639},{"date":"2024-06-14","current":-212.492085,"twenty":14.156908,"median":29.278446,"eighty":41.339259,"marketCap":154269254},{"date":"2024-06-21","current":-203.777899,"twenty":14.123085,"median":28.941526,"eighty":41.369578,"marketCap":147942755},{"date":"2024-06-28","current":-205.788865,"twenty":14.101821,"median":28.815898,"eighty":41.369578,"marketCap":149402716},{"date":"2024-07-05","current":-205.118543,"twenty":14.061456,"median":28.592041,"eighty":41.369578,"marketCap":148916062},{"date":"2024-07-12","current":-210.48112,"twenty":13.995991,"median":28.46557,"eighty":41.369578,"marketCap":152809293},{"date":"2024-07-15","current":-211.151442,"twenty":13.995991,"median":28.446337,"eighty":41.369578,"marketCap":153295947},{"date":"2024-08-02","current":-221.876594,"twenty":13.965764,"median":28.594514,"eighty":41.395649,"marketCap":161082407},{"date":"2024-08-09","current":-155.153276,"twenty":13.890161,"median":28.447288,"eighty":41.369578,"marketCap":158411495},{"date":"2024-08-16","current":-157.547617,"twenty":13.879322,"median":28.196854,"eighty":41.040322,"marketCap":160856117},{"date":"2024-08-23","current":-158.026486,"twenty":13.823503,"median":28.008512,"eighty":39.690077,"marketCap":161345042},{"date":"2024-08-30","current":-166.167244,"twenty":13.795681,"median":27.935383,"eighty":38.544,"marketCap":169656756},{"date":"2024-09-06","current":-154.195541,"twenty":13.753035,"median":27.569737,"eighty":38.347232,"marketCap":157433647},{"date":"2024-09-13","current":-151.322331,"twenty":13.704502,"median":27.313784,"eighty":38.122137,"marketCap":154500100},{"date":"2024-09-20","current":-156.111013,"twenty":13.672394,"median":27.130961,"eighty":37.980944,"marketCap":159389344},{"date":"2024-09-27","current":-154.195541,"twenty":13.62697,"median":26.595041,"eighty":37.894382,"marketCap":157433647},{"date":"2024-10-04","current":-155.153276,"twenty":13.599214,"median":26.468913,"eighty":37.779744,"marketCap":158411495},{"date":"2024-10-11","current":-150.364595,"twenty":13.553316,"median":26.233285,"eighty":37.589923,"marketCap":153522252},{"date":"2024-10-18","current":-152.280068,"twenty":13.524775,"median":26.107151,"eighty":37.433759,"marketCap":155477949},{"date":"2024-10-25","current":-147.012518,"twenty":13.48942,"median":25.919114,"eighty":37.27024,"marketCap":150099781},{"date":"2024-10-31","current":-150.364595,"twenty":13.450324,"median":25.485552,"eighty":37.015362,"marketCap":153522252},{"date":"2024-11-08","current":-52.964156,"twenty":13.423662,"median":24.845672,"eighty":36.750798,"marketCap":162811815},{"date":"2024-11-15","current":-53.318651,"twenty":13.387469,"median":24.004684,"eighty":36.556933,"marketCap":163901532},{"date":"2024-11-22","current":-53.238832,"twenty":13.341574,"median":23.198637,"eighty":36.327656,"marketCap":163656170},{"date":"2024-11-29","current":-58.905934,"twenty":13.314055,"median":22.981027,"eighty":36.238493,"marketCap":181076842},{"date":"2024-12-06","current":-58.267387,"twenty":13.27171,"median":22.651653,"eighty":35.999189,"marketCap":179113949},{"date":"2024-12-13","current":-58.427024,"twenty":13.239501,"median":22.455197,"eighty":35.783905,"marketCap":179604672},{"date":"2024-12-20","current":-55.074654,"twenty":13.19425,"median":21.621859,"eighty":35.607032,"marketCap":169299486},{"date":"2024-12-27","current":-53.957197,"twenty":13.130069,"median":21.342486,"eighty":35.505726,"marketCap":165864424},{"date":"2025-01-03","current":-51.88192,"twenty":13.070245,"median":21.138876,"eighty":35.459393,"marketCap":159485023},{"date":"2025-01-10","current":-49.96628,"twenty":13.021327,"median":20.901601,"eighty":35.211692,"marketCap":153596345},{"date":"2025-01-17","current":-51.88192,"twenty":12.972548,"median":20.664813,"eighty":35.117714,"marketCap":159485023},{"date":"2025-01-24","current":-51.562647,"twenty":12.952487,"median":20.578494,"eighty":35.032487,"marketCap":158503577},{"date":"2025-01-31","current":-49.168097,"twenty":12.915203,"median":20.138975,"eighty":34.93156,"marketCap":151142730},{"date":"2025-02-07","current":-51.083737,"twenty":12.802486,"median":19.831317,"eighty":34.780123,"marketCap":157031408},{"date":"2025-02-14","current":-51.40301,"twenty":12.725025,"median":19.519993,"eighty":34.72983,"marketCap":158012854},{"date":"2025-02-21","current":-49.48737,"twenty":12.667751,"median":19.333199,"eighty":34.575342,"marketCap":152124176},{"date":"2025-02-28","current":-49.00846,"twenty":12.601316,"median":19.122141,"eighty":34.324158,"marketCap":150652007},{"date":"2025-03-07","current":53.583718,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":152124176},{"date":"2025-03-14","current":56.52218,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":160466470},{"date":"2025-03-21","current":63.229713,"twenty":12.589786,"median":18.928478,"eighty":34.39907,"marketCap":179509154},{"date":"2025-03-28","current":64.079574,"twenty":12.589786,"median":18.928478,"eighty":34.546571,"marketCap":181921911},{"date":"2025-04-04","current":63.569657,"twenty":12.589786,"median":18.928478,"eighty":34.686729,"marketCap":180474257},{"date":"2025-04-11","current":60.17021,"twenty":12.590422,"median":18.990743,"eighty":34.733776,"marketCap":170823227},{"date":"2025-04-17","current":62.889768,"twenty":12.590422,"median":18.990743,"eighty":34.814432,"marketCap":178544051},{"date":"2025-04-25","current":62.379851,"twenty":12.589786,"median":18.928478,"eighty":34.943677,"marketCap":177096396},{"date":"2025-05-02","current":64.589491,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":183369566},{"date":"2025-05-09","current":25.015629,"twenty":12.589786,"median":18.928478,"eighty":35.046539,"marketCap":193020596},{"date":"2025-05-13","current":29.987043,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":231380025}],"updateTime":1747291373007}}}